RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
ROCKET PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$2.24+0.06 (+2.75%)
Close on Oct 19, 2026
- Market cap
- $256.51M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Rocket Pharmaceuticals has not reported a dividend
No dividend per share appears in Rocket Pharmaceuticals's annual filings since fiscal 2013.